The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Astrocytes—Friends or foes in multiple sclerosis?
Abstract
In multiple sclerosis (MS), the presence of demyelinating plaques has concentrated researchers' minds on the role of the oligodendrocyte in its pathophysiology. Recently, with the rediscovery of early and widespread loss of axons in the disease, new emphasis has been put on the role of axons and axon‐oligodendrocyte interactions in MS. Despite the fact that, in 1904, Müller claimed that MS was a disease of astrocytes, more recently, astrocytes have taken a back seat, except as the cells that form the final glial scar after all hope of demyelination is over. However, perhaps it is time for the return of the astrocyte to popularity in the pathogenesis of MS, with recent reports on the dual role of astrocytes in aiding degeneration and demyelination, by promoting inflammation, damage of oligodendrocytes and axons, and glial scarring, but also in creating a permissive environment for remyelination by their action on oligodendrocyte precursor migration, oligodendrocyte proliferation, and differentiation. We review these findings to try to provide a cogent view of astrocytes in the pathology of MS. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Astrocyte activation and reactive gliosis
Pekny, M., & Nilsson, M. (2005) · Glia · doi:10.1002/glia.20207 · Cited by 1,611
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Molecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Cyclosporine induces cancer progression by a cell-autonomous mechanism
Hojo, M., Morimoto, T., Maluccio, M., Asano, T., Morimoto, K., Lagman, M., Shimbo, T., & Suthanthiran, M. (1999) · Nature · doi:10.1038/17401 · Cited by 1,149
Transforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System
Steinman, M. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81107-1 · Cited by 903
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino, M. A., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9292 · Cited by 807
Astrocytes present myelin basic protein to encephalitogenic T-cell lines
Fontana, A., Fierz, W., & Wekerle, H. (1984) · Nature · doi:10.1038/307273a0 · Cited by 771
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj, K., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 738
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M. E., Woody, J. N., Hartung, H.-P., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 733
Notch Receptor Activation Inhibits Oligodendrocyte Differentiation
Wang, S., Sdrulla, A. D., diSibio, G., Bush, G., Nofziger, D., Hicks, C., Weinmaster, G., & Barres, B. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80515-2 · Cited by 705
Astrocytes promote myelination in response to electrical impulses
Ishibashi, T., Dakin, K. A., Stevens, B., Lee, P. R., Kozlov, S. V., Stewart, C. L., & Fields, R. D. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.006 · Cited by 689
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
Induction of myelination in the central nervous system by electrical activity
Demerens, C., Stankoff, B., Logak, M., Anglade, P., Allinquant, B., Couraud, F., Zalc, B., & Lubetzki, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9887 · Cited by 678
Self-citationA Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements
Hargreaves, D. C., Hyman, P. L., Lu, T. T., Ngo, V. N., Bidgol, A., Suzuki, G., Zou, Y.-R., Littman, D. R., & Cyster, J. G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.45 · Cited by 659
Beck, K. D., Powell-Braxtont, L., Widmer, H.-R., Valverde, J., & Hefti, F. (1995) · Neuron · doi:10.1016/0896-6273(95)90216-3 · Cited by 636 · cited 2×
“, 1993) and those with a disrupted IGF-1 gene have smaller brains, fewer oligodendrocytes, and less myelin content (Beck et al., 1995).”
BackgroundEssential protective roles of reactive astrocytes in traumatic brain injury
Myer, D. J. (2006) · Brain · doi:10.1093/brain/awl165 · Cited by 617
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
Astrocyte Responses to CNS Injury
NORENBERG, M. D. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199405000-00001 · Cited by 589
Huang, D., Wang, J., Kivisakk, P., Rollins, B. J., & Ransohoff, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.713 · Cited by 583
Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisäkk, P., Ransohoff, R. M., Hofbauer, M., Farina, C., Derfuss, T., Hartle, C., et al. (2006) · Brain · doi:10.1093/brain/awh680 · Cited by 561
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
Mcdonald, J. W., Althomsons, S. P., Hyrc, K. L., Choi, D. W., & Goldberg, M. P. (1998) · Nature Medicine · doi:10.1038/nm0398-291 · Cited by 544
Stevens (2002) · doi:10.1016/s0896-6273(02)01067-x · Cited by 543
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
De Stefano, N., Narayanan, S., Francis, G. S., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., Matthews, P. M., & Arnold, D. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.65 · Cited by 505
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., & Tuohy, V. K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8472896 · Cited by 496
Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C.-M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041674 · Cited by 492
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death
Louis, J.-C., Magal, E., Takayama, S., & Varon, S. (1993) · Science · doi:10.1126/science.8430320 · Cited by 486
John, G. R., Shankar, S. L., Shafit-Zagardo, B., Massimi, A., Lee, S. C., Raine, C. S., & Brosnan, C. F. (2002) · Nature Medicine · doi:10.1038/nm781 · Cited by 477
Wilhelmsson, U., Li, L., Pekna, M., Berthold, C.-H., Blom, S., Eliasson, C., Renner, O., Bushong, E., Ellisman, M., Morgan, T. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0820-04.2004 · Cited by 455
The Role of Glial Reaction and Inflammation in Parkinson's Disease
HIRSCH, E. C., BREIDERT, T., ROUSSELET, E., HUNOT, S., HARTMANN, A., & MICHEL, P. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07478.x · Cited by 449
Rash, J. E., Yasumura, T., Dudek, F. E., & Nagy, J. I. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01983.2001 · Cited by 430
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00208-7 · Cited by 408
Pekny, M., Johansson, C. B., Eliasson, C., Stakeberg, J., Wallén, Å., Perlmann, T., Lendahl, U., Betsholtz, C., Berthold, C.-H., & Frisén, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.503 · Cited by 405
Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., & Kollias, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11294 · Cited by 403
Linker, R. A., Mäurer, M., Gaupp, S., Martini, R., Holtmann, B., Giess, R., Rieckmann, P., Lassmann, H., Toyka, K. V., Sendtner, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-620 · Cited by 398
Tsai, H.-H., Frost, E., To, V., Robinson, S., ffrench-Constant, C., Geertman, R., Ransohoff, R. M., & Miller, R. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00838-3 · Cited by 387
Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.
McMorris, F. A., Smith, T. M., DeSalvo, S., & Furlanetto, R. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.822 · Cited by 386
McManus, C., Berman, J. W., Brett, F. M., Staunton, H., Farrell, M., & Brosnan, C. F. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00002-2 · Cited by 380
Chemokine expression in murine experimental allergic encephalomyelitis
Godiska, R., Chantry, D., Dietsch, G. N., & Gray, P. W. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00008-p · Cited by 353
Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
Matute, C., Sánchez-Gómez, M. V., Martínez-Millán, L., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8830 · Cited by 352
Gijbels, K., Galardy, R. E., & Steinman, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117578 · Cited by 339
IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes
Hsieh, J., Aimone, J. B., Kaspar, B. K., Kuwabara, T., Nakashima, K., & Gage, F. H. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200308101 · Cited by 334
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
Maimone, D., Gregory, S., Arnason, B. G. W., & Reder, A. T. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90073-g · Cited by 333
Qin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R., & Antel, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 320
Magliozzi, R., Columba-Cabezas, S., Serafini, B., & Aloisi, F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.056 · Cited by 317
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., & Probert, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316
Taub, D. D., Turcovski-Corrales, S. M., Key, M. L., Longo, D. L., & Murphy, W. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2095 · Cited by 308
Karpus, W. J., & Kennedy, K. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.681 · Cited by 306
Zhang, K., McQuibban, G. A., Silva, C., Butler, G. S., Johnston, J. B., Holden, J., Clark-Lewis, I., Overall, C. M., & Power, C. (2003) · Nature Neuroscience · doi:10.1038/nn1127 · Cited by 305
Furie, M. B., & Randolph, G. J. (1995) · Europe PMC (PubMed Central) · Cited by 297
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. A., & Oksenberg, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5133 · Cited by 294
Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 291
Axonal loss in normal-appearing white matter in a patient with acute MS
Bjartmar, C., Kinkel, R. P., Kidd, G., Rudick, R. A., & Trapp, B. D. (2001) · Neurology · doi:10.1212/wnl.57.7.1248 · Cited by 281
Glabinski, A. R., Tani, M., Strieter, R. M., Tuohy, V. K., & Ransohoff, R. M. (1997) · PubMed · Cited by 280
Stankoff, B., Aigrot, M.-S., Noël, F., Wattilliaux, A., Zalc, B., & Lubetzki, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09221.2002 · Cited by 262
Self-citationDubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den Oord, J., Sciot, R., Meinhardt, T., Hämmerling, G., Opdenakker, G., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6886 · Cited by 262
Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G., & Yong, V. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11127.2003 · Cited by 260
Expression of MCP-1 by Reactive Astrocytes in Demyelinating Multiple Sclerosis Lesions
Van Der Voorn, P., Tekstra, J., Beelen, R. H. J., Tensen, C. P., Van Der Valk, P., & De Groot, C. J. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65249-2 · Cited by 258
Bö, L., Mörk, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90075-2 · Cited by 256
Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J. (2003) · Annals of Neurology · doi:10.1002/ana.10443 · Cited by 252
Directional Guidance of Oligodendroglial Migration by Class 3 Semaphorins and Netrin-1
Spassky, N., de Castro, F., Le Bras, B., Heydon, K., Quéraud-LeSaux, F., Bloch-Gallego, E., Chédotal, A., Zalc, B., & Thomas, J.-L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05992.2002 · Cited by 249
A role for TGF-beta in oligodendrocyte differentiation.
McKinnon, R. D., Piras, G., Ida, J. A., & Dubois-Dalcq, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.6.1397 · Cited by 248
Injury‐induced Regulation of Ciliary Neurotrophic Factor mRNA in the Adult Rat Brain
Ip, N. Y., Wiegand, S. J., Morse, J., & Rudge, J. S. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00201.x · Cited by 246
Berman, J. W., Guida, M. P., Warren, J., Amat, J., & Brosnan, C. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.3017 · Cited by 244
Woodroofe, M. N., & Cuzner, M. L. (1993) · Cytokine · doi:10.1016/s1043-4666(05)80008-0 · Cited by 243
Tanuma, N., Sakuma, H., Sasaki, A., & Matsumoto, Y. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0083-7 · Cited by 237
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
Waubant, E., Goodkin, D. E., Gee, L., Bacchetti, P., Sloan, R., Stewart, T., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234
A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors
Dziembowska, M., Tham, T. N., Lau, P., Vitry, S., Lazarini, F., & Dubois-Dalcq, M. (2005) · Glia · doi:10.1002/glia.20170 · Cited by 233
The contribution of demyelination to axonal loss in multiple sclerosis
DeLuca, G. C. (2006) · Brain · doi:10.1093/brain/awl074 · Cited by 231
Baker, D., Butler, D., Scallon, B. J., O'Neill, J. K., Turk, J. L., & Feldmann, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240916 · Cited by 229
Hayashi, M., Luo, Y., Laning, J., Strieter, R. M., & Dorf, M. E. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00064-9 · Cited by 226
Komoly, S., Hudson, L. D., Webster, H. D., & Bondy, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1894 · Cited by 223
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
Pitt, D., Nagelmeier, I. E., Wilson, H. C., & Raine, C. S. (2003) · Neurology · doi:10.1212/01.wnl.0000090564.88719.37 · Cited by 222
Hinks, G. L., & Franklin, R. J. M. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0771 · Cited by 219
Hulkower, K., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., & Berman, J. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2525 · Cited by 215
Benefit of valproic acid in suppressing disease progression of ALS model mice
Sugai, F., Yamamoto, Y., Miyaguchi, K., Zhou, Z., Sumi, H., Hamasaki, T., Goto, M., & Sakoda, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03765.x · Cited by 214
Owens, G. P., Ritchie, A. M., Burgoon, M. P., Williamson, R. A., Corboy, J. R., & Gilden, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2725 · Cited by 209
DE GROOT, C. J. A., RUULS, S. R., M. THEEUWES, J. W., DIJKSTRA, C. D., & DER VALK, P. V. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199701000-00002 · Cited by 206
Johnatty, R. N., Taub, D. D., Reeder, S. P., Turcovski-Corrales, S. M., Cottam, D. W., Stephenson, T. J., & Rees, R. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2327 · Cited by 205
Krogsgaard, M., Wucherpfennig, K. W., Canella, B., Hansen, B. E., Svejgaard, A., Pyrdol, J., Ditzel, H., Raine, C., Engberg, J., & Fugger, L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1395 · Cited by 197
Determinants of Human B Cell Migration Across Brain Endothelial Cells
Alter, A., Duddy, M., Hebert, S., Biernacki, K., Prat, A., Antel, J. P., Yong, V. W., Nuttall, R. K., Pennington, C. J., Edwards, D. R., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4497 · Cited by 195
Talbott, J. F., Loy, D. N., Liu, Y., Qiu, M. S., Bunge, M. B., Rao, M. S., & Whittemore, S. R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.038 · Cited by 194
Wang, X., Tay, S. S.-W., & Ng, Y.-K. (2000) · Experimental Brain Research · doi:10.1007/s002210000360 · Cited by 191
Bajetto, A., Barbero, S., Bonavia, R., Piccioli, P., Pirani, P., Florio, T., & Schettini, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00350.x · Cited by 186
Selmaj, K., Papierz, W., Glabinski, A., & Kohno, T. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00139-f · Cited by 177
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
Cossins, J. A., Clements, J. M., Ford, J., Miller, K. M., Pigott, R., Vos, W., Van Der Valk, P., & De Groot, C. J. A. (1997) · Acta Neuropathologica · doi:10.1007/s004010050754 · Cited by 176
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
Avolio, C., Ruggieri, M., Giuliani, F., Liuzzi, G. M., Leante, R., Riccio, P., Livrea, P., & Trojano, M. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00006-7 · Cited by 176
Guidance of glial precursor cell migration by secreted cues in the developing optic nerve
Sugimoto, Y., Taniguchi, M., Yagi, T., Akagi, Y., Nojyo, Y., & Tamamaki, N. (2001) · Development · doi:10.1242/dev.128.17.3321 · Cited by 171
Mozell, R. L., & McMorris, F. A. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300214 · Cited by 170
Calderon, T. M., Eugenin, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., & Berman, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.003 · Cited by 168
Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection
Haskell, C. A., Hancock, W. W., Salant, D. J., Gao, W., Csizmadia, V., Peters, W., Faia, K., Fituri, O., Rottman, J. B., & Charo, I. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12976 · Cited by 167
Lindberg, R. L. P. (2001) · Brain · doi:10.1093/brain/124.9.1743 · Cited by 166
Stidworthy, M. F. (2004) · Brain · doi:10.1093/brain/awh217 · Cited by 158
Generation and Analysis of Mice Lacking the Chemokine Fractalkine
Cook, D. N., Chen, S., Sullivan, L. M., Manfra, D. J., Wiekowski, M., Prosser, D. M., Vassileva, G., & Lira, S. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3159-3165.2001 · Cited by 157
Larsen, P. H., DaSilva, A. G., Conant, K. E., & Yong, V. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1880-05.2006 · Cited by 156
Matsumoto, Y., Ohmori, K., & FUJIWARA, M. T. (1992) · PubMed · Cited by 154
Nikcevich, K. M., Gordon, K. B., Tan, L., Hurst, S. D., Kroepfl, J. F., Gardinier, M. V., Barrett, T. A., & Miller, S. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.614 · Cited by 150
Lee, S. C., Moore, G. R. W., Golenwsky, G., & Raine, C. S. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199003000-00005 · Cited by 149
Interleukin-11 Potentiates Oligodendrocyte Survival and Maturation, and Myelin Formation
Zhang, Y., Taveggia, C., Melendez‐Vasquez, C. V., Einheber, S., Raine, C. S., Salzer, J. L., Brosnan, C. F., & John, G. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2289-06.2006 · Cited by 148
Barna, B. P., Pettay, J., Barnett, G. H., Zhou, P., Iwasaki, K., & Estes, M. L. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90220-8 · Cited by 146
Uhm, J. H., Dooley, N. P., Oh, L. Y. S., & Yong, V. W. (1998) · Glia · doi:10.1002/(sici)1098-1136(199801)22:1<53::aid-glia5>3.0.co;2-9 · Cited by 146
Fainardi, E., Castellazzi, M., Bellini, T., Manfrinato, M. C., Baldi, E., Casetta, I., Paolino, E., Granieri, E., & Dallocchio, F. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1274oa · Cited by 145 · cited 1×
“…in active lesions (Cossins et al., 1997; Diaz-Sanchez et al., 2006; Maeda and Sobel, 1996; van Horssen et al., 2006), and MMP expression in serum and cerebrospinal fluid (CSF) is also increased, especially in active disease (Avolio et al., 2003; Fainardi et al., 2006; Kanesaka et al., 2006).”
BackgroundIncreased expression and function of glutamate transporters in multiple sclerosis
Vallejo‐Illarramendi, A., Domercq, M., Pérez‐Cerdá, F., Ravid, R., & Matute, C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.017 · Cited by 145
Interleukin-6 is elevated in plasma in multiple sclerosis
Krei, K., Fredrikson, S., Fontana, A., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90020-8 · Cited by 145
Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex
da Cunha, A., Jefferson, J. A., Jackson, R. W., & Vitković, L. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90214-j · Cited by 142
Taupin, V., Renno, T., Bourbonnière, L., Peterson, A. C., Rodriguez, M., & Owens, T. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270416 · Cited by 140
Franklin, R. J. M., Crang, A. J., & Blakemore, W. F. (1991) · Journal of Neurocytology · doi:10.1007/bf01355538 · Cited by 136
TNF-α mediates SDF-1α–induced NF-κB activation and cytotoxic effects in primary astrocytes
Han, Y., He, T., Huang, D., Pardo, C. A., & Ransohoff, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12629 · Cited by 134
Bridges, R. J., & Esslinger, C. S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.002 · Cited by 132
Hurwitz, A. A., Lyman, W. D., & Herman, J. W. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00011-p · Cited by 130
Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats
Kuroda, Y., & Shimamoto, Y. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90125-q · Cited by 129
TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation
Gimenez, M. A. T., Sim, J. E., & Russell, J. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.012 · Cited by 128
Dopamine Receptor Modulation of Hypoxic—Ischemic Neuronal Injury in Striatum of Newborn Piglets
Yang, Z.-J., Torbey, M., Li, X., Bernardy, J., Golden, W. C., Martin, L. J., & Koehler, R. C. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600440 · Cited by 127
Integrin‐growth factor interactions as regulators of oligodendroglial development and function
Baron, W., Colognato, H., & ffrench‐Constant, C. (2004) · Glia · doi:10.1002/glia.20132 · Cited by 126
Sunnemark, D., Eltayeb, S., Nilsson, M., Wallström, E., Lassmann, H., Olsson, T. P., Berg, A., & Ericsson‐Dahlstrand, A. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-17 · Cited by 125
The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers
Mackay, F., & Tangye, S. G. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.02.009 · Cited by 123
Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor
Bugga, L., Gadient, R. A., Kwan, K. W., Stewart, C. L., & Patterson, P. H. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19980915)36:4<509::aid-neu5>3.0.co;2-# · Cited by 123
Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo
Gomez-Pinilla, F., Vu, L., & Cotman, C. W. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02021.1995 · Cited by 120
Tan, L., Gordon, K. B., Mueller, J. P., Matis, L. A., & Miller, S. D. (1998) · PubMed · Cited by 118
Cellular immune response in multiple sclerosis plaques.
Boyle, E. A., & McGeer, P. L. (1990) · PubMed Central · Cited by 115
Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia
Bannerman, P. G. C., Hahn, A., Soulika, A. M., Gallo, V., & Pleasure, D. (2006) · Glia · doi:10.1002/glia.20437 · Cited by 115
Rindfleisch, E. (1863) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01878008 · Cited by 115
Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
Rodriguez, M., Pavelko, K. D., Mckinney, C., & Leibowitz, J. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3811 · Cited by 113
Astrocyte‐associated axonal damage in pre‐onset stages of experimental autoimmune encephalomyelitis
Wang, D., Ayers, M. M., Catmull, D. V., Hazelwood, L. J., Bernard, C. C. A., & Orian, J. M. (2005) · Glia · doi:10.1002/glia.20199 · Cited by 112
Soos, J. M., Morrow, J., Ashley, T. A., Szente, B. E., Bikoff, E. K., & Zamvil, S. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5959 · Cited by 110
Liu, X., Yao, D., Bondy, C. A., Brenner, M., Hudson, L. D., Zhou, J., & Webster, H. D. (1994) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1994.1052 · Cited by 105
Axonal Injury or Loss in the Internal Capsule and Motor Impairment in Multiple Sclerosis
Lee, M. A., Blamire, A. M., Pendlebury, S. T., Ho, K.-H., Mills, K. R., Styles, P., Palace, J. A., & Matthews, P. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.65 · Cited by 99
A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients
Frank, J. A., Richert, N. D., Lewis, B. K., Bash, C. N., Howard, T., Civil, R. H., Stone, R. D., Eaton, J. K., McFarland, H. F., & Leist, T. P. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms768oa · Cited by 99
Albrecht, P. J., Murtie, J. C., Ness, J. K., Redwine, J. M., Enterline, J. R., Armstrong, R. C., & Levison, S. W. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00019-6 · Cited by 99
McMorris, F. A., Mozell, R. L., Carson, M. J., Shinar, Y., MEYER, R. D., & MARCHETTI, N. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26247.x · Cited by 99
Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis
Juryńczyk, M., Jurewicz, A., Bielecki, B., Raine, C. S., & Selmaj, K. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.10.013 · Cited by 98
Crocker, S. J., Whitmire, J. K., Frausto, R. F., Chertboonmuang, P., Soloway, P. D., Whitton, J. L., & Campbell, I. L. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060626 · Cited by 96
Tan, L., Gordon, K. B., Mueller, J. P., Matis, L. A., & Miller, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4271 · Cited by 96
Interleukin-6 expression in human multiple sclerosis lesions
Schönrock, L. M., Gawlowski, G., & Brück, W. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01543-3 · Cited by 95
Fischer, F. R., Santambrogio, L., Luo, Y., Berman, M. A., Hancock, W. W., & Dorf, M. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00351-9 · Cited by 95
Navikas, V., Matusevičius, D., Söderström, M. B., Fredrikson, S., Kivisäkk, P., Ljungdahl, Å., Höjeberg, B., & Link, H. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00155-7 · Cited by 94
Willenborg, D. O., Fordham, S. A., Cowden, W. B., & Ramshaw, I. A. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03530.x · Cited by 94
Hulshof, S. C. J., van Haastert, E. S., Kuipers, H. F., van den Elsen, P. J., Groot, C. J. A. D., van der Valk, P., Ravid, R., & Biber, K. P. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.899 · Cited by 93
Corley, S. M., Ladiwala, U., Besson, A., & Yong, V. W. (2001) · Glia · doi:10.1002/glia.1116 · Cited by 93
Ulrich, R., Baumgärtner, W., Gerhauser, I., Seeliger, F., Haist, V., Deschl, U., & Alldinger, S. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229990.32795.0d · Cited by 92
Mansour, H., Asher, R., Dahl, D. R., Labkovsky, B., Perides, G., & Bignami, A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490250306 · Cited by 91
Padberg, F., Feneberg, W. W., Schmidt, S., Schwarz, M., Körschenhausen, D. A., Greenberg, B. D., Nolde, T., Müller, N., Trapmann, H., König, N., et al. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00120-4 · Cited by 88
Thangarajh, M., Gomes, A. C., Masterman, T., Hillert, J. A., & Hjelmström, P. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.03.017 · Cited by 86
Effects of TNFα on immature and mature oligodendrocytes and their progenitors in vitro
Cammer, W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02178-8 · Cited by 84
Lovett‐Racke, A. E., Bittner, P., Cross, A. H., Carlino, J. A., & Racke, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1486 · Cited by 84
Chromosome 19 Single-Locus and Multilocus Haplotype Associations With Multiple Sclerosis
Barcellos, L. F. (1997) · JAMA · doi:10.1001/jama.278.15.1256 · Cited by 81
Protein co-expression with axonal injury in multiple sclerosis plaques
Diaz-Sanchez, M., Williams, K., DeLuca, G. C., & Esiri, M. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0045-0 · Cited by 80
Mandler, R. N., Dencoff, J. D., Midani, F., Ford, C. C., Ahmed, W., & Rosenberg, G. A. (2001) · Brain · doi:10.1093/brain/124.3.493 · Cited by 77
Raine, C. S., Bonetti, B., & Cannella, B. (1998) · PubMed · Cited by 75
Horwitz, M. S., Evans, C. F., Klier, F. G., & Oldstone, M. B. A. (1999) · PubMed · Cited by 75
Blakemore, W. F., Gilson, J. M., & Crang, A. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00347-9 · Cited by 74
Ransohoff, R. M., & Estes, M. L. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530240048017 · Cited by 74
Venance, L., Cordier, J., Monge, M., Zalc, B., Glowinski, J., & Giaume, C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00341.x · Cited by 74
Prevention of Experimental Autoimmune Encephalomyelitis by MIP-1α and MCP-1 Naked DNA Vaccines
Youssef, S., Wildbaum, G., & Karin, N. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0306 · Cited by 73
Cannella, B., Pitt, D., Capello, E., & Raine, C. S. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64606-8 · Cited by 72
Ödemis, V., Moepps, B., Gierschik, P., & Engele, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200472200 · Cited by 70
Seifert‐Held, T., Bauer, J., Weissert, R., Fazekas, F., & Storch, M. K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0170-9 · Cited by 69
Saneto, R. P., Low, K. G., Melner, M. H., & de Vellis, J. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490210213 · Cited by 67
Promoting repair in multiple sclerosis: problems and prospects
Lubetzki, C., Williams, A., & Stankoff, B. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169739.83793.e0 · Cited by 66
Self-citationMultiple nicht eitrige Encephalomyelitis und multiple Sklerose
Anton, G., & Wohlwill, F. (1912) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02866371 · Cited by 66
Matrix metalloproteinase‐19 is highly expressed in active multiple sclerosis lesions
van Horssen, J., Vos, C. M. P., Admiraal, L., van Haastert, E. S., Montagne, L., van der Valk, P., & de Vries, H. E. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00766.x · Cited by 64
Larsen, P. H., & Yong, V. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2092-04.2004 · Cited by 64
Jenkins, H. G., & Ikeda, H. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90194-p · Cited by 62
Tuohy, T. M. F., Wallingford, N. M., Liu, Y., Chan, F. H., Rizvi, T. A., Xing, R., Bebo, B. F., Rao, M. S., & Sherman, L. S. (2004) · Glia · doi:10.1002/glia.20042 · Cited by 62
Differential Oligodendroglial Expression of the Tumor Necrosis Factor Receptors In Vivo and In Vitro
Tchélingérian, J., Monge, M., Saux, F. L., Zalc, B., & Jacque, C. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052377.x · Cited by 61
Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination
Plant, S. R., Arnett, H. A., & Ting, J. P. (2005) · Glia · doi:10.1002/glia.20089 · Cited by 60
Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12
Maysami, S., Nguyen, D., Zobel, F., Pitz, C., Heine, S., Höpfner, M., & Stangel, M. (2006) · Neuroreport · doi:10.1097/01.wnr.0000227985.92551.9a · Cited by 60
Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases
Taylor, P. C., Williams, R. O., & Feldmann, M. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.09.005 · Cited by 57
D'Amelio, F. E., Smith, M. E., & Eng, L. F. (1990) · Glia · doi:10.1002/glia.440030402 · Cited by 54
Li, W., Quigley, L., Yao, D. L., Hudson, L. D., Brenner, M., Zhang, B. J., Brocke, S., McFarland, H. F., & Webster, H. D. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00006 · Cited by 53
Kort, J., Kawamura, K., Fugger, L. H., Weissert, R., & Forsthuber, T. G. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.014 · Cited by 52
Diemel, L. T., Jackson, S. J., & Cuzner, M. L. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10837 · Cited by 52
Failure of Remyelination in the Nonhuman Primate Optic Nerve
Lachapelle, F., Bachelin, C., Moissonnier, P., Nait‐Oumesmar, B., Hidalgo, A., Fontaine, D., & Evercooren, A. B. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00521.x · Cited by 49
Chromosome 19 Single-Locus and Multilocus Haplotype Associations With Multiple Sclerosis
Barcellos, L. F. (1997) · JAMA · doi:10.1001/jama.1997.03550150060036 · Cited by 46
Kanesaka, T., Mori, M., Hattori, T., Oki, T., & Kuwabara, S. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.068619 · Cited by 42
Serologic analysis of the mouse beta chemokine JE/monocyte chemoattractant protein-1.
Luo, Y., Laning, J. C., Hayashi, M., Hancock, P. R., Rollins, B. J., & Dorf, M. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3708 · Cited by 41
Genoud, S., Maricic, I., Kumar, V., & Gage, F. H. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.033 · Cited by 39
A unique population of circulating autoantibodies promotes central nervous system remyelination
Asakura, K., & Rodriguez, M. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400324 · Cited by 38
Heinrich, M., Gorath, M., & Richter‐Landsberg, C. (1999) · Glia · doi:10.1002/(sici)1098-1136(199912)28:3<215::aid-glia5>3.0.co;2-c · Cited by 38
The potential use of MMP inhibitors to treat CNS diseases
Yong, V. W. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.3.255 · Cited by 36
Jakob, A. (1915) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02870557 · Cited by 29
Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death
Plo, I., Ghandour, S., Feutz, A.-C., Clanet, M., Laurent, G., & Bettaïeb, A. (1999) · Neuroreport · doi:10.1097/00001756-199908020-00028 · Cited by 27
Butter, C., O'Neill, J. K., Baker, D., Gschmeissner, S. E., & Turk, J. L. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90032-3 · Cited by 25
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair
Domingues, H. S., Portugal, C. C., Socodato, R., & Relvas, J. B. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00071 · Cited by 432
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
Cohen, J. A., & Chun, J. (2011) · Annals of Neurology · doi:10.1002/ana.22426 · Cited by 393
Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., Berger, K., Kipp, M., Baumgärtner, W., & Stangel, M. (2013) · Brain · doi:10.1093/brain/aws262 · Cited by 376
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 375
“Astrocytes in MS are considered to possess a dual role since beneficial as well as detrimental effects of astrocytes on de- and remyelination are being discussed (Williams et al., 2007; Nair et al., 2008; Kipp et al., 2011a; Moore et al., 2011).”
Background
Metadata
- Authors
- Williams, A., Piaton, G., & Lubetzki, C.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2007-07-30
- Volume
- 55
- Issue
- 13
- Pages
- 1300-1312
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2084887202
- Cited by
- 302
- References
- 205
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.